<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Asston Pharmaceuticals Limited has filed an initial disclosure with BSE confirming that it does not qualify as a 'Large Corporate' under SEBI guidelines. The company reported outstanding borrowings of Rs. 5.04 Crores as of March 31, 2024. No credit rating is applicable as the company does not meet the large corporate threshold. This filing is a routine regulatory compliance exercise required under SEBI circulars to be completed within 30 days of the financial year beginning. The company was formerly known as Asston Pharmaceuticals Private Limited before becoming a public listed entity.
This filing has no direct impact on the stock price as it is a routine compliance confirmation. The company's modest borrowings of Rs. 5.04 Crores indicate it does not fall into the high-debt category requiring enhanced disclosure norms under SEBI's Large Corporate framework.